Pacira BioSciences, Inc.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing non-opioid options to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid options for treating pain: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.
Products & Services Offered
EXPAREL, iovera and ZILRETTA
Category
Pharmaceuticals
Contact Information
Gigi Kisling
Sr. Mgr, Commercial Operations & Events
Tel: (908) 295-6137
5 Sylvan Way, Suite 300
Parsippany, NJ 07054
www.pacira.com/